control

Control peptide version of dynamin inhibitory peptide, myristoylated, an inhibitor of the GTPase dynamin that competitively blocks binding of dynamin to amphiphysin, preventing endocytosis. In contrast to dynamin inhibitory peptide, has no significant eff

Trometamol (Tromethamine) is a proton acceptor used to treat acidemia. It inhibits both isoforms of cyclooxygenases (COX1 and COX2), thereby blocking the conversion of arachidonic acid to pro-inflammatory pro-prostaglandins.

Trometamol hydrochloride (TRIS hydrochloride) (Tromethamine hydrochloride) is a biologically inert amino alcohol with low toxicity. Trometamol hydrochloride buffers carbon dioxide and acids in vitro and in vivo. Trometamol hydrochloride is an effective amine compound for pH control in the physiological range.

TH-263 is inactive toward both LIMK1 and LIMK2 and thus can be used as negative control for TH-257, and is a diaryl sulfonamide derivative.

inactive analog of the 3-phosphoglycerate dehydrogenase (PHGDH) inhibitors NCT-502 and NCT-503

PS-47(PS 47) is an inactive E-isomer of PS48. PS48 is an activator of PDK1.

BRD5648 ((R)-BRD0705) is an inactive (R)-enantiomer of BRD0705, a GSK3α inhibitor with an IC50 of 66 nM and a Kd of 4.8 μM, used in acute myeloid leukemia [AML] studies.

KN-92 phosphate (KN92-H3PO4) is an inactive derivative of KN-93. KN-93 is a selective inhibitor of Ca2+/calmodulin-dependent kinase II (CaMKII), competitively blocking CaM binding to the kinase (Ki = 370 nM).

KN-92 hydrochloride is an inactive derivative of the selective Ca2+/calmodulin-dependent kinase II (CaMKII) inhibitor KN-93, which competitively blocks CaM binding to the kinase with a Ki of 370 nM.

Human IgG1 kappa, Isotype Control is a humanized IgG-like monoclonal antibody and an isotype control antibody for human IgG1κ.

Fibronectin Active Fragment Control acetate is an active fragment of fibronectin which is a glycoprotein.

The PKR Inhibitor, negative control, is an inactive structural analog of RNA-dependent protein kinase (PKR) inhibitors, serving as a negative control. Additionally, it can inhibit LK-induced neuronal death, demonstrating significant neuroprotective properties.

saRNA negative control is a type of saRNA that can be used as a negative control.

Volanesorsenscramble negative control is the negative control form of Volanesorsen with the sequence: CAUGUTCUTCUGCATGUCAU. Volanesorsen (ISIS 304801) is an antisense oligonucleotide inhibitor targeting apolipoprotein CIII (apo-CIII) mRNA, effectively reducing triglyceride levels and improving insulin resistance.

GalNac-siRNA negative control (21nt) serves as the negative control form of GalNac-siRNA. GalNac-siRNA is an inhibitor conjugate targeting the asialoglycoprotein receptor (ASGPR). This compound holds potential for research into hereditary transthyretin amyloidosis, acute hepatic porphyria, hemophilia, and hypercholesterolemia.

Cy5-MicroRNA Mimic Negative Control is a Cy5-labeled MicroRNA Mimic Negative Control. This compound is a 21-nucleotide miRNA mimic used as a negative control. The sequence of the MicroRNA Mimic Negative Control is designed based on the cel-mir-239b sequence, which is widely utilized as a negative control. It exhibits minimal sequence homology with human, mouse, and rat miRNA.

siRNA negative control (In Vivo) is an siRNA designed to serve as a negative control. It is modified with cholesterol and methoxy groups, making it suitable as a negative control in animal studies.

Elebsiran scramble negative control is a scrambled sequence variant of Elebsiran, utilizing the same modification method. This compound serves as a negative control for Elebsiran.

Emapticap pegol scramble negative control, an oligonucleotide aptamer, serves as the negative control for Emapticap pegol.

GAPDH siRNA Positive Control (Mouse/Rat) is an siRNA product serving as a positive control for mouse and rat GAPDH siRNA.

GAPDH Positive Control siRNA (Human) is a siRNA product that serves as a positive control for human GAPDH siRNA.

Negative control for TBK1 PROTAC 3i. Binds TBK1 with high affinity, but exhibits no significant degradation of TBK1. PROTAC is a registered trademark of Arvinas Operations, Inc., and is used under license.

ELA-14 negative control is an inactive peptide that serves as a negative control for ELA-14.

ARCC 4 negative control is a negative control for ARCC 4. Binds androgen receptors (AR) without inducing degradation.